TrialInvestigational new drugs2009

Results of a Phase II trial of gemcitabine, mitoxantrone, and rituximab in relapsed or refractory mantle cell lymphoma.

Lawrence E Garbo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.